Journal
The New England Journal of Medicine
Publication Date
2010
Volume
363
Issue
19
Inclusive Pages
1812-1821
Document Type
Open Access Publication
DOI
pdf/10.1056/NEJMoa1002965
Rights and Permissions
Younes, A., Bartlett, N. L., Leonard, J. P., Kennedy, D. A., Lynch, C. M., Sievers, E. L., & Forero-Torres, A. (2010). Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas. New England Journal of Medicine, 363(19), 1812-1821. Copyright © 2010 Massachusetts Medical Society. doi: 10.1056/NEJMoa1002965. http://www.nejm.org/doi/pdf/10.1056/NEJMoa1002965.
Recommended Citation
Younes, Anas; Bartlett, Nancy L.; Leonard, John P.; Kennedy, Dana A.; Lynch, Carmel M.; Sievers, Eric L.; and Forero-Torres, Andres, "Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas." The New England Journal of Medicine. 363, 19. 1812-1821. (2010).
https://digitalcommons.wustl.edu/open_access_pubs/3146
